In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years;
* Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma);
* Patients deemed fit for surgical or multimodal treatment;
* Informed consent obtained;
* Treatment, including multimodal treatment, involving surgery.
E…
Inclusion Criteria:
* Age ≥ 18 years;
* Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma);
* Patients deemed fit for surgical or multimodal treatment;
* Informed consent obtained;
* Treatment, including multimodal treatment, involving surgery.
Exclusion Criteria:
* Histology other than adenocarcinoma or squamous cell carcinoma;
* Other neoplastic diseases concurrent with or undergoing treatment or treated with systemic therapies in the previous three years;
* Age \<18 years;
* No need for surgery.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.